Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin. - Wikidata - wikimedia - TriplyDB

Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin.

Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin.

http://www.wikidata.org/entity/Q34999293

about

Selective incorporation of 5-hydroxytryptophan into proteins in mammalian cells Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1 Hyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine design An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cells.HIV-1 receptor binding site-directed antibodies using a VH1-2 gene segment orthologue are activated by Env trimer immunization A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies Structure of the HIV-1 gp41 Membrane-Proximal Ectodomain Region in a Putative Prefusion Conformation † , ‡Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120 Extensive Mutagenesis of the HSV-1 gB Ectodomain Reveals Remarkable Stability of Its Postfusion Form A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies Comparative immunogenicity of HIV-1 gp160, gp140 and gp120 expressed by live attenuated newcastle disease virus vector A directed molecular evolution approach to improved immunogenicity of the HIV-1 envelope glycoprotein Recent advances on the use of structural biology for the design of novel envelope immunogens of HIV-1 Comparison of immunogenicity between codon optimized HIV-1 Thailand subtype B gp140 and gp145 vaccines.A plant-produced H1N1 trimeric hemagglutinin protects mice from a lethal influenza virus challenge.Oligomer-specific conformations of the human immunodeficiency virus (HIV-1) gp41 envelope glycoprotein ectodomain recognized by human monoclonal antibodies B cell recognition of the conserved HIV-1 co-receptor binding site is altered by endogenous primate CD4.Preparation of recombinant viral glycoproteins for novel and therapeutic antibody discovery.A strategy for eliciting antibodies against cryptic, conserved, conformationally dependent epitopes of HIV envelope glycoprotein Effect of trimerization motifs on quaternary structure, antigenicity, and immunogenicity of a noncleavable HIV-1 gp140 envelope glycoprotein.Influence of novel CD4 binding-defective HIV-1 envelope glycoprotein immunogens on neutralizing antibody and T-cell responses in nonhuman primates Characterization of gp120 and its single-chain derivatives, gp120-CD4D12 and gp120-M9: implications for targeting the CD4i epitope in human immunodeficiency virus vaccine design.Breadth of neutralizing antibodies elicited by stable, homogeneous clade A and clade C HIV-1 gp140 envelope trimers in guinea pigs Functional chimeras of human immunodeficiency virus type 1 Gp120 and influenza A virus (H3) hemagglutinin Oligomerization triggered by foldon: a simple method to enhance the catalytic efficiency of lichenase and xylanase.HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV.Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1 Antibody-secreting B cells in HIV infection.Biochemical and immunogenic characterization of soluble human immunodeficiency virus type 1 envelope glycoprotein trimers expressed by semliki forest virus.Comparing antigenicity and immunogenicity of engineered gp120.Siglecs facilitate HIV-1 infection of macrophages through adhesion with viral sialic acids.A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals.Novel recombinant engineered gp41 N-terminal heptad repeat trimers and their potential as anti-HIV-1 therapeutics or microbicides Human anti-HIV-neutralizing antibodies frequently target a conserved epitope essential for viral fitness.Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates.Immunization with wild-type or CD4-binding-defective HIV-1 Env trimers reduces viremia equivalently following heterologous challenge with simian-human immunodeficiency virus.Induction of neutralizing antibodies against human immunodeficiency virus type 1 primary isolates by Gag-Env pseudovirion immunization.Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants HIV-1 Env-specific memory and germinal center B cells in C57BL/6 mice Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.

P2860

Q24562667-07A506C9-A9B8-42EA-9E67-1356681DEA92 Q24645530-7158AD56-60BF-4FBE-8200-C47D18348163 Q24679395-1F25BFDF-DF7D-411C-AD42-AEDD10E85890 Q25256583-2F2B5E26-D7AF-4734-A4C2-4FF575A93BE4 Q27324184-408AD574-01C0-4C8F-9A94-A824805B4523 Q27485578-F7170E84-D3BA-43D9-8F2B-730173B777EE Q27653846-43B6B6AB-E404-4A89-86FE-DAF9DBD7AFF8 Q27658449-3EAE5A72-D9C3-47C8-B237-0BA0FA7BA0E5 Q27676847-8140E8B3-32B5-43F7-B859-DB1C862F5F02 Q28299280-54935E92-E6BB-42C2-926B-55844941AE07 Q28533970-8697B678-CFC0-4656-81D6-BF9059D35387 Q28743092-6B326046-27F6-4FA2-A38C-B8D931E4B2DE Q30353580-DC11CE8D-8869-4B24-8E48-2B0BB4658DC8 Q30360326-5324BEBB-D364-4815-B92E-0CC96ADCFB40 Q30425590-DE0B53DA-216A-43E0-999D-1E067B3B830F Q30436401-908208DB-FB8B-4F8C-8D88-97889B5BA276 Q33373664-FAF575C3-DCF6-4746-8F5A-257F98FD10C6 Q33413784-6372AF23-9F98-45FD-857B-C8A471659588 Q33522232-2ADD2CE4-4860-4F1B-9C9B-08596D31ED31 Q33571825-141AFB95-6566-40C7-8249-DAF51A3D0D8D Q33614605-60EF478B-322D-4B00-9D21-C89C5694F53D Q33717477-A4A3D5C4-A0D3-4439-BEA1-5A25CCD6DFBC Q33725679-2748B8D2-A2FC-4EC3-9862-E9074DAB2AB8 Q33780529-21E4552F-7052-4B47-A952-2AFB052E360B Q33868388-2B76A3AE-F5C6-442D-932A-C2A90C4F641E Q33869332-A67F819D-C517-4E78-AF42-E48C6682013E Q33883887-032E7942-6269-401A-800D-88EADD0A347D Q33914185-AA5CC49B-8396-4DD4-9D77-7A208D59A9F1 Q33930424-0E0F4721-6BDA-47A2-8CF8-86DF7752B601 Q33984309-EECBC1B8-58EE-4E82-8155-78230CF9867D Q34023679-151A91BB-DE82-4E99-8502-BCCDD36ABD68 Q34047445-BA3267BF-1634-4016-B925-84640AB64F2B Q34055847-1A788832-6589-4467-8AAF-CABC56E18793 Q34096475-F18E8F59-A39B-486B-9778-D4F1AB1C4AAC Q34096530-070C43C1-7CC3-451A-8AD1-C77823D1E76E Q34120088-A8697B7F-0B8F-4BFD-A321-37743AFF9E4B Q34142795-A0A0605F-2D3D-490C-AF8B-2873A187B7E5 Q34302085-3F300A4B-ABF2-48F2-8D4C-4596D9E0DB94 Q34303547-E591F7AD-C00D-490A-A63A-176E142BA12C Q34361680-5A476C97-DC62-4A6B-8448-6523440271A0

P2860

Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin.

http://www.wikidata.org/entity/Q34999293

description

2002 nî lūn-bûn

@nan

2002 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Highly stable trimers formed b ...... of T4 bacteriophage fibritin.

@ast

Highly stable trimers formed b ...... of T4 bacteriophage fibritin.

@en

Highly stable trimers formed b ...... of T4 bacteriophage fibritin.

@nl

type

label

Highly stable trimers formed b ...... of T4 bacteriophage fibritin.

@ast

Highly stable trimers formed b ...... of T4 bacteriophage fibritin.

@en

Highly stable trimers formed b ...... of T4 bacteriophage fibritin.

@nl

prefLabel

Highly stable trimers formed b ...... of T4 bacteriophage fibritin.

@ast

Highly stable trimers formed b ...... of T4 bacteriophage fibritin.

@en

Highly stable trimers formed b ...... of T4 bacteriophage fibritin.

@nl

P1433

Q34999293-D4141AC2-A6E8-4B0A-A5E9-675A3C073B87

P1476

Q34999293-A0E3D471-F8E5-4EE4-89AB-CD23D17214E2

P2093

Q34999293-34A3FC71-9825-4ACD-B952-BC87CF31153E

Q34999293-7BCE71EF-1804-4DAC-8D74-ABE75BB744B4

Q34999293-81E98CFF-2A17-41C7-8EE3-0C6BC585D384

Q34999293-92887D72-07E2-49CB-BB37-0FEE7B025A36

Q34999293-A779E8AA-EFA6-4E6F-AADB-B6584DF2BA0A

P2860

Q34999293-06048E9D-E016-4AB8-91BF-7263835F7E3C

Q34999293-0C8F58F7-B8A2-4A09-92B5-0CB6A82A1F83

Q34999293-1CE09EE0-C791-47FC-8C23-31158343F053

Q34999293-1FEAE021-2C3E-4857-9C50-2942E05A4320

Q34999293-2099D99D-ED86-4030-98FC-A6318CA64CE4

Q34999293-2808A055-F4B2-488C-AD55-77D00B09879F

Q34999293-3C1281EC-A989-4F6F-9735-CADD50321986

Q34999293-3E6B7D91-F242-44DA-A6C8-B319352E0A86

Q34999293-40DF947A-D222-465C-804C-7E84C3EF6E1C

Q34999293-4169C68F-3879-43C7-AA7C-7100FA8383D3

P304

Q34999293-B506A88E-08C1-48DA-87D2-15EA5D246890

P31

Q34999293-30C094E2-FCBB-4593-9E50-C0A3A55B13EB

P356

Q34999293-CE0657B8-2F2F-42FF-ACF0-FB095FDE9DB5

P407

Q34999293-EA2E46ED-2CCD-46E5-9011-B9398E4594FF

P433

Q34999293-FAEED650-B9B6-426C-9D14-54BE08BFA52D

P478

Q34999293-6A94EA81-DF04-4FB9-80C4-C62254F0C9E3

P50

Q34999293-8B378714-0B24-4FC3-85D6-A55F6DDBE602

P577

Q34999293-D07F86CF-42FB-4AF2-B6C8-3B96F68DD479

P698

Q34999293-AB360D5C-4BE3-40DA-91FE-64BCEC674F38

P921

Q34999293-92029E03-8D56-4B0C-BB07-2C08C4684606

P932

Q34999293-6E899AB6-38C5-44EB-9692-017082819F81

P356

JVI.76.9.4634-4642.2002

P1433

Journal of Virology

P1476

Highly stable trimers formed b ...... of T4 bacteriophage fibritin.

@en

P2093

Erin M Mahony

http://www.w3.org/2001/XMLSchema#string

Juliette Lee

http://www.w3.org/2001/XMLSchema#string

Peter D Kwong

http://www.w3.org/2001/XMLSchema#string

Richard Wyatt

http://www.w3.org/2001/XMLSchema#string

Xinzhen Yang

http://www.w3.org/2001/XMLSchema#string

P2860

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

Identification of a major co-receptor for primary isolates of HIV-1

Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines.

Crystal structure of SIV matrix antigen and implications for virus assembly

Core structure of gp41 from the HIV envelope glycoprotein

Atomic structure of the ectodomain from HIV-1 gp41

Structure of bacteriophage T4 fibritin: a segmented coiled coil and the role of the C-terminal domain

Atomic structure of a thermostable subdomain of HIV-1 gp41

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

P304

4634-4642

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.76.9.4634-4642.2002

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P50

Joseph Sodroski

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11932429

http://www.w3.org/2001/XMLSchema#string

P921

P932

155086

http://www.w3.org/2001/XMLSchema#string